TP53 and inflammatory bowel disease: A proper understanding of genetic mutations should allow a better stratification of IBD patients according to their risk for dysplasia and invasive carcinoma, in order to personalize their treatment and surveillance; for example, a recent study found that architectural distortion seems to be significantly correlated with p53 and p21 overexpression in epithelial cells.